Yosef Safi Harb’s Post

As we enter 2024 with optimism for a rebound in Medtech M&A and deal volumes, I reflected on what Ramin Mousavi, CEO of CathWorks, shared on-stage at LSI USA ‘23 on the value of building and nurturing a team worth acquiring. In breaking down the CathWorks journey and exit, Ramin and co-panelists Chris Eso of Medtronic, Andrew ElBardissi, MD of Deerfield Management, Sabing Lee of Knobbe Martens explored what goes in to a Medtech acquisition, how to position your company for a deal, and what elements of the acquisition often get neglected. One insight Ramin shared that stuck with me in particular: “When strategics buy a company, they buy three things — a technology, a market, and a management team.” The technology and market components are well-explored in the dialogue around M&A, but the management team component tends to get lost in the broader narrative. You can’t drag your team through an acquisition — you need their push back on your ideas to force you to think and act in ways that stimulate progress and growth. While the the CEO job is a very lonely job as Ramin highlights, surrounding yourself with a management team that you can be vulnerable with and, in turn, knows they don’t have to agree with you simply to appease you creates the healthy pressure from which gems are born. Especially in M&A, where the talent is often as important as the tech. You can watch this full panel, The Anatomy of a Medtech Deal, here: https://lnkd.in/e_qmNW8b And stay tuned for the release of panels scheduled for LSI USA ‘24 this March.

Heading to meet with Quality Means Business in Boston ahead of an exciting two days at the LSX Global Medtech conference. Michel E. Moravia, MBA, MSE continues to amaze me with his insight, leadership, and resilience as QMB heads into the next stage of its development. The journey of the start-up is NOT for the faint of heart. Humbled to be a part of an incredible board and supporting an honorable and humble leader working hard to bring a product to the market that is not only unique but will improve safety for patients and decrease wasted resources for companies bringing technology to the marketplace in a safer and more efficient manner. I am excited to hear the presentations at LSX - partnering for Life Science eXecutives, network with innovators and thought leaders, and am thrilled to help share the experience and expertise of the panel as we discuss Cash, Crew, & Commercialization: A Start-Ups Journey to Success. On Friday, I head to Portugal to attend the 3rd annual LSI Emerging Medtech Summit as Scott Pantel continues to drive incredible value globally for the world of Medtech. The technology, leadership, networking, presentations, and thought leaders never disappoints. As I am halfway through my 10th year in the industry leading Shurig Solutions, Inc., I am humbled daily by the opportunity to be involved in our space and the goal of bringing improved patient outcomes, patient access, and increased efficiency to the healthcare system. As this last 1.5 years has been extremely challenging for many relevant to the economy, numerous layoffs, the challenges of raising capital, and an incredibly competitive landscape, I continue to be amazed at the resiliency and strength of so many Medtech leaders, service providers, and friends that I have been blessed to meet, know, and partner with. As Dr Joe Dyspenza always says…. Gratitude is the ultimate form of receivership. 🙏. I am grateful for the opportunity to attend, learn, and grow! #innovation #medtech #resilience #giftofgratitude #neverstoplearning #growthmindset #networking

Discover Frost & Sullivan's latest Growth Content, unveiling fresh growth prospects in medical technology. Download now to capitalize on these opportunities for transformative growth. 🔍 Key Questions: ✅ Is your growth strategy aligned with evolving customer needs? ✅ Are you leveraging disruptive tech for accelerated growth? ✅ How are you overcoming hurdles to advance growth? ✅ Is your team exploring medical tech opportunities to stay competitive? Don't miss out! Download today and propel your organization forward in the medical tech sector: https://hubs.la/Q02BJHBP0 #MedicalTech #Growth #Innovation #GrowthContent

Medical Technology CFO Trends: United States Q3 2024 Sharing a recap of CFO changes and market trends for publicly traded, medical technology companies, based in the US during Q3 2024. If you would like to discuss leadership trends in the medical technology space and what our team is hearing in the market, please feel free to reach out.

Major shifts are underway in the medical tech sector as corporate spin-offs redefine strategies. Executives aim to enhance focus, boost profits, and improve investor returns. Let's explore the transformative trends in the industry! 💼🔄 #CorporateStrategy #MedTech

Heading Home with Fresh Insights! After an eventful week at The MedTech Conference in Toronto and meetings with clients across the region, I’m wrapping up my trip with one last stop in the Big Apple 🗽. Reflecting on the experience, here are my BIG 3 TAKEAWAYS from the week: 1. The EU Market Remains Critical for Medtech Companies Despite the regulatory challenges and fragmented reimbursement systems, the EU continues to be a key market for medtech companies. It remains essential for delivering solid returns to investors. However, companies outside Europe increasingly need experienced, hands-on partners to successfully navigate these complexities. It's no longer just about consulting - it's about deep collaboration throughout the entire process to penetrate the market effectively. 2. Innovation is the Lifeblood of Medtech Whether through product-market fit optimization, improving patient outcomes, integrating AI, or advancing commercialization strategies, medtech innovation is indispensable. Expanding into consumer markets is also emerging as a significant trend, underscoring the versatility companies must maintain. To stay competitive, companies are increasingly streamlining operations—such as outsourcing engineering and manufacturing—so they can focus on the core areas of innovation that truly drive value. 3. Medtech is a Fast-Paced, Dynamic Industry The constant evolution of areas like cybersecurity, regulation, testing, and technical cost reduction makes it nearly impossible to sustain in-house expertise for long. As soon as you build expertise in one area, it's already becoming outdated. As soon as you built a large team to work on a pressing topic, this team is needed somewhere else, but might lack the skillset to effectively tackle it. As a result, medtech companies are increasingly acting as integrators, creating networks of experts to stay ahead of the rapid changes. At Corscience GmbH & Co.KG we are well-positioned to address the challenges US and Canadian medtech companies face. Having completed hundreds of projects of complex, safety-critical medical products globally, we bring a wealth of experience to the table. Our deep expertise in EU regulations and comprehensive project management - from R&D through to regulatory approval - helps our partners bring products to market faster and more efficiently. By working across multiple projects at the forefront of medtech innovation, we can identify potential issues and trends early and offer quick, effective solutions. Excited to apply these insights and continue supporting our US and Canadian partners as they navigate this vibrant and rapidly changing industry! #Medtech #Innovation #Collaboration #EUmarket #Corscience

Medical Technology CFO Trends: United States Q2 2024 Sharing a recap of CFO changes and market trends for publicly traded, medical technology companies, based in the US in Q2 2024. If you would like to discuss leadership trends in the medical technology space and what our team is hearing in the market, please feel free to reach out!

Discover Frost & Sullivan's latest Growth Content, unveiling fresh growth prospects in medical technology. Download now to capitalize on these opportunities for transformative growth. 🔍 Key Questions: ✅ Is your growth strategy aligned with evolving customer needs? ✅ Are you leveraging disruptive tech for accelerated growth? ✅ How are you overcoming hurdles to advance growth? ✅ Is your team exploring medical tech opportunities to stay competitive? Don't miss out! Download today and propel your organization forward in the medical tech sector: https://hubs.la/Q02BJj100 #MedicalTech #Growth #Innovation #GrowthContent

A resurgence in MedTech over the next 12 months? That is what a room full of investors and MedTech executives overwhelmingly predicted last week at the MedTech MVP conference in Minneapolis. Many of these very same leaders referred to the last 1.5 years as MedTech Winter due to the difficulty raising capital. Which in turn, constrained growth and in some cases resulted in companies ceasing commercial operations, even when they had technologies that would improve the standard of care. And now we are moving into MedTech Spring! The question is are you and your team ready to grow? Or will you let your competitors take the lead and crowd you out? The time to prepare is now! Contact Due North for talent to fuel your growth! #medtechrecruiter #hightechrecruiter #marketingrecruiting #salesrecruiting

A resurgence in MedTech over the next 12 months? That is what a room full of investors and MedTech executives overwhelmingly predicted last week at the MedTech MVP conference in Minneapolis. Many of these very same leaders referred to the last 1.5 years as MedTech Winter due to the difficulty raising capital. Which in turn, constrained growth and in some cases resulted in companies ceasing commercial operations, even when they had technologies that would improve the standard of care. And now we are moving into MedTech Spring! The question is are you and your team ready to grow? Or will you let your competitors take the lead and crowd you out? The time to prepare is now! Contact Due North for talent to fuel your growth! #medtechrecruiter #hightechrecruiter #marketingrecruiting #salesrecruiting